Close
References for Welcome to RapidCME
ADDITIONAL RESOURCES:
- Female Sexual Function Index (FSFI): http://www.fsfiquestionnaire.com/
- Female Sexual Distress Scale – Revised (FSDS-R):
DeRogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med. 2008;5(2):357-364. - Free & Bioavailable Testosterone Calculator: http://www.issam.ch/freetesto.htm
REFERENCES:
1. Clayton AH, Goldstein I, Kim NN, et al. The International Society for the Study of Women’s Sexual Health
Process of Care for Management of Hypoactive Sexual Desire Disorder in Women. Mayo Clin Proc.
2018;93(4):467-487.
2. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States
women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970-978.
3. Berman L, Berman J, Felder S, et al. Seeking help for sexual function complaints: what gynecologists need to
know about the female patient's experience. Fertil Steril. 2003;79(3):572-576.
4. World Health Organization. Defining sexual health.
http://www.who.int/reproductivehealth/topics/sexual_health/sh_definitions/en/. Accessed July 10, 2018.
5. Korenman SG. New insights into erectile dysfunction: a practical approach. Am J Med. 1998;105(2):135-144.
6. Eid JF, Sadovsky R. “Primary care: A perfect setting for discussing sexual health.” Cliniguide to Erectile
Dysfunction. New York, NY: Lawrence DellaCorte Publications, Inc; 2001.
7. Heinemann J, Atallah S, Rosenbaum T. The impact of culture and ethnicity on sexuality and sexual function.
Curr Sex Health Rep. 2016;8(3):144-150.
8. Kingsberg SA, Janata JW. Female sexual disorders: assessment, diagnosis, and treatment. Urol Clin North
Am. 2007;34(4):497-506, v-vi.
9. Sadovsky R, Alam W, Enecilla M, Cosiquien R, Tipu O, Etheridge-Otey J. Sexual problems among a specific
population of minority women aged 40-80 years attending a primary care practice. J Sex Med.
2006;3(5):795-803.
10. Sadovsky R, Nusbaum M. Sexual health inquiry and support is a primary care priority. J Sex Med.
2006;3(1):3-11.
11. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder
and in women with hypoactive sexual desire disorder. J Sex Marital Ther. 2003;29(1):39-46.
12. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report
instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.
13. DeRogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress
scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med.
2008;5(2):357-364.
14. Parish SJ, Goldstein AT, Goldstein SW, et al. Toward a more evidence-based nosology and nomenclature for
female sexual dysfunctions-part II. J Sex Med. 2016;13(12):1888-1906.
15. Parish SJ, Hahn SR. Hypoactive sexual desire disorder: A review of epidemiology, biopsychology, diagnosis,
and treatment. Sex Med Rev. 2016;4(2):103-120.
16. Worsley R, Santoro N, Miller KK, Parish SJ, Davis SR. Hormones and female sexual dysfunction: Beyond
estrogens and androgens--Findings from the Fourth International Consultation on Sexual Medicine. J Sex
Med. 2016;13(3):283-290.
17. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine
Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-288.
18. Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004;363(9411):793-803.
19. Cooper DS. Hyperthyroidism. Lancet. 2003;362(9382):459-468.
20. Klein DA, Poth MA. Amenorrhea: an approach to diagnosis and management. Am Fam Physician.
2013;87(11):781-788.
21. Rosen RC, Barsky JL. Normal sexual response in women. Obstet Gynecol Clin North Am. 2006;33(4):
515-526.
22. Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary
syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the
Study of Women's Sexual Health and the North American Menopause Society. Menopause.
2014;21(10):1063-1068.
23. Woods NF, Mitchell ES. Consequences of incontinence for women during the menopausal transition and early
postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause. 2013;20(9):
915-921.
24. Salonia A, Zanni G, Nappi RE, et al. Sexual dysfunction is common in women with lower urinary tract
symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol. 2004;45(5):642-648;
discussion 648.
25. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a
survey of Western European women. J Sex Med. 2006;3(2):212-222.
26. Pontiroli AE, Cortelazzi D, Morabito A. Female sexual dysfunction and diabetes: a systematic review and
meta-analysis. J Sex Med. 2013;10(4):1044-1051.
27. Trompeter SE, Bettencourt R, Barrett-Connor E. Metabolic Syndrome and Sexual Function in Postmenopausal
Women. Am J Med. 2016;129(12):1270-1277.e1.
28. Kolotkin RL, Binks M, Crosby RD, Ostbye T, Mitchell JE, Hartley G. Improvements in sexual quality of life after
moderate weight loss. Int J Impot Res. 2008;20(5):487-492.
29. Kingsberg SA, Rezaee RL. Hypoactive sexual desire in women. Menopause. 2013;20(12):1284-1300.
30. Mohammadi K, Rahnama P, Mohseni SM, Sahraian MA, Montazeri A. Determinants of sexual dysfunction in
women with multiple sclerosis. BMC Neurol. 2013;13:83.
31. Hajiaghababaei M, Javidan AN, Saberi H, et al. Female sexual dysfunction in patients with spinal cord injury:
a study from Iran. Spinal Cord. 2014;52(8):646-649.
32. Zeleke BM, Bell RJ, Billah B, Davis SR. Hypoactive sexual desire dysfunction in community-dwelling older
women. Menopause. 2017;24(4):391-399.
33. Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic
review and meta-analysis. J Sex Med. 2012;9(6):1497-1507.
34. Buster JE. Managing female sexual dysfunction. Fertil Steril. 2013;100(4):905-915.
35. Giraldi A, Kristensen E, Sand M. Endorsement of models describing sexual response of men and women with
a sexual partner: an online survey in a population sample of Danish adults ages 20-65 years. J Sex Med.
2015;12(1):116-128.
36. Ferenidou F, Kirana PS, Fokas K, Hatzichristou D, Athanasiadis L. Sexual Response Models: Toward a More
Flexible Pattern of Women's Sexuality. J Sex Med. 2016;13(9):1369-1376.
37. Carvalheira AA, Brotto LA, Leal I. Women's motivations for sex: exploring the diagnostic and statistical
manual, fourth edition, text revision criteria for hypoactive sexual desire and female sexual arousal disorders.
J Sex Med. 2010;7(4 Pt 1):1454-1463.
38. Kingsberg SA, Woodard T. Female sexual dysfunction: focus on low desire. Obstet Gynecol.
2015;125(2):477-486.
39. Kling JM, Manson JE, Naughton MJ, et al. Association of sleep disturbance and sexual function in
postmenopausal women. Menopause. 2017;24(6):604-612.
40. Morin M, Carroll MS, Bergeron S. Systematic review of the effectiveness of physical therapy modalities in
women With provoked vestibulodynia. Sex Med Rev. 2017;5(3):295-322.
41. Ferreira CH, Dwyer PL, Davidson M, De Souza A, Ugarte JA, Frawley HC. Does pelvic floor muscle training
improve female sexual function? A systematic review. Int Urogynecol J. 2015;26(12):1735-1750.
42. Nastri CO, Lara LA, Ferriani RA, Rosa-E-Silva AC, Figueiredo JB, Martins WP. Hormone therapy for sexual
function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013(6):CD009672.
43. Reichenpfader U, Gartlehner G, Morgan LC, et al. Sexual dysfunction associated with second-generation
antidepressants in patients with major depressive disorder: results from a systematic review with network
meta-analysis. Drug Saf. 2014;37(1):19-31.
44. Lorenz TA, Meston CM. Exercise improves sexual function in women taking antidepressants: results from a
randomized crossover trial. Depress Anxiety. 2014;31(3):188-195.
45. Khamba B, Aucoin M, Lytle M, et al. Efficacy of acupuncture treatment of sexual dysfunction secondary to
antidepressants. J Altern Complement Med. 2013;19(11):862-869.
46. Hirschfeld RM. Management of sexual side effects of antidepressant therapy. J Clin Psychiatry. 1999;60 Suppl
14:27-30; discussion 31-25.
47. Spire Learning. Personal communication with expert James A. Simon, MD, March 26, 2018.
48. Pyke RE, Clayton AH. Psychological Treatment Trials for Hypoactive Sexual Desire Disorder: A Sexual
Medicine Critique and Perspective. J Sex Med. 2015;12(12):2451-2458.
49. Hucker A, McCabe MP. Incorporating Mindfulness and Chat Groups Into an Online Cognitive Behavioral
Therapy for Mixed Female Sexual Problems. J Sex Res. 2015;52(6):627-639.
50. Brotto LA, Basson R. Group mindfulness-based therapy significantly improves sexual desire in women. Behav
Res Ther. 2014;57:43-54.
51. Sarwer DB, Durlak JA. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions. J Sex
Marital Ther. 1997;23(2):87-97.
52. Fruhauf S, Gerger H, Schmidt HM, Munder T, Barth J. Efficacy of psychological interventions for sexual
dysfunction: a systematic review and meta-analysis. Arch Sex Behav. 2013;42(6):915-933.
53. Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of
chronic pain. J Behav Med. 1985;8(2):163-190.
54. Brotto LA, Krychman M, Jacobson P. Eastern approaches for enhancing women's sexuality: mindfulness,
acupuncture, and yoga (CME). J Sex Med. 2008;5(12):2741-2748; quiz 2749.
55. Silverstein RG, Brown AC, Roth HD, Britton WB. Effects of mindfulness training on body awareness to sexual
stimuli: implications for female sexual dysfunction. Psychosom Med. 2011;73(9):817-825.
56. Sprout Pharmaceuticals, Inc. ADDYI Prescribing Information.
https://www.fda.gov/downloads/Drugs/DrugSafety/UCM459254.pdf. Published 2015. Accessed
July 10, 2018.
57. Katz M, DeRogatis LR, Ackerman R, et al. Efficacy of flibanserin in women with hypoactive sexual desire
disorder: results from the BEGONIA trial. J Sex Med. 2013;10(7):1807-1815.
58. Thorp J, Simon J, Dattani D, et al. Treatment of hypoactive sexual desire disorder in premenopausal women:
efficacy of flibanserin in the DAISY study. J Sex Med. 2012;9(3):793-804.
59. DeRogatis LR, Komer L, Katz M, et al. Treatment of hypoactive sexual desire disorder in premenopausal
women: efficacy of flibanserin in the VIOLET Study. J Sex Med. 2012;9(4):1074-1085.
60. Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M Jr, Sand M. Efficacy and safety of flibanserin in
postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause.
2014;21(6):633-640.
61. Stevens DM, Weems JM, Brown L, Barbour KA, Stahl SM. The pharmacodynamic effects of combined
administration of flibanserin and alcohol. J Clin Pharm Ther. 2017;42(5):598-606.
62. Sicard E, Raimondo D, Vittow J, et al. Effect of alcohol administered with flibanserin on dizziness, syncope,
and hypotension in healthy, premenopausal women. Presented at: 23rd Congress of the World Association for
Sexual Health; May 28-31, 2017; Prague, Czech Republic.
63. Clayton AH, Lucas J, Jordan R, Spana C. Poster presented at: The 30th ECNP Congress of Applied and
Translational Neuroscience; September 2-5, 2017. Paris, France. Poster P.1.g.042.
64. Clayton AH, Lucas J, DeRogatis LR, Jordan R. Phase I randomized placebo-controlled, double-blind study of
the safety and tolerability of bremelanotide coadministered with ethanol in healthy male and female
participants. Clin Ther. 2017;39(3):514-526.e14.
65. Tuiten A, van Rooij K, Bloemers J, et al. Efficacy and safety of on-demand use of 2 treatments designed for
different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials. J Sex Med.
2018;15(2):201-216.
66. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically
menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90(9):5226-5233.
67. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal
women: a randomized trial. Obstet Gynecol. 2005;105(5 Pt 1):944-952.
68. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire
disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause.
2006;13(5):770-779.
69. Fiers T, Kaufman JM. Free & Bioavailable Testosterone Calculator. http://www.issam.ch/freetesto.htm.
Accessed July 10, 2018.
70. Guay A, Munarriz R, Jacobson J, et al. Serum androgen levels in healthy premenopausal women with and
without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of
sexual dysfunction. Int J Impot Res. 2004;16(2):112-120.
71. Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society
clinical practice guideline. J Clin Endocrinol Metab. 2014;99(10):3489-3510.